Abstract:N-(3-fluoro-4-((6-methoxy-7-(3-(4-methylpiperazin-1-yl) propoxy) quinolin-4-yl) oxy) phenyl)-1-(2-fluorophenyl)-4-methyl-5-oxo-4,5-dihydro-1 H-1,2,4-triazole-3-carboxamide (LJC-116) is a kind of new Type Ⅱ compounds,c-Met kinase inhibitors with 4-phenoxy quinolone.In vitro experiments showed that they have an excellent anti-tumor activity.In this paper,the in vitro molecular binding interaction between LJC-116 and human serum albumin(HSA) was further inves tigated by various methods,such as fluorescence spectrometry,synchronous fluorescence spectrometry,fluorescence probe experiments,three-dimensional(3-D) fluorescence spectrometry,ultraviolet-visible (UV-Vis) absorption spectroscopy and molecular docking.It was found that the intrinsic fluo rescence of HSA could be quenched by LJC-116 through a static quenching process.The static quenching process was also proved by 3-D fluorescence spectrometry and ultraviolet-visible absorption spectroscopy.The apparent binding constants between LJC-116 and HSA at 288,299,310 K were estimated to be in the order of 104 L · mo1-1,which indicated the binding between LJC-116 and HSA was moderate.The thermodynamic parameters △H°,△G° and △S° were calculated,in which the negative △G° suggested that the binding of LJC-116 to HSA was spontaneous.Moreover,the positive △S° and negative △H° revealed that hydrophobic interaction and hydrogen bonds were the major forces to stabilize the protein-LJC-116 (1 ∶ 1) complex.Under the experimental conditions,the overlapping integral J =7.169 7 × 10-15 cm3 · L · mol-1,R =1.28 nm,r =1.69 nm,E =15.6％ were obtained.It indicated a high probability of energy transfer from HSA to LJC-116.Probe agent ibuprofen and warfarin were added in system of HSA-LJC-116,it showed that the primary binding site of LJC-116 was located at site Ⅰ (subdomain Ⅱ A) of HSA.The slight redshift of fluorescence(0.3 nm),synchronous fluorescence(0.4 nm) and 3-D fluorescence spectra(2 nm) all demonstrated that the polarity of microenvironment for amino acid residues in HSA increased and the hydrophobic property decreased.Finally,the forces deduced from the thermodynamic calculation,and the conformational changes of HSA were validated by the molecular docking.The interaction mechanism of HSA and LJC-116 was comprehensively expatiated at a molecular level in this paper,and some useful information for the transport of Type Ⅱ c-met kinase inhibitors in vivo was provided.

Investigation on In Vitro Binding of a New Anti-tumor Compound and Human Serum Albumin by Spectroscopic Methods and Molecular Docking

Evaluation of Molecular Binding Modes on Site Ii of Human Serum Albumin

Molecular Simulations on Dynamic Binding of Ibuprofen Onto Site II of Human Serum Albumin: One Potential Way Analysis

Study on the Interaction of Two Quinazoline Derivatives As Novel PI3K/mTOR Dual Inhibitors and Anticancer Agents to Human Serum Albumin Utilizing Spectroscopy and Docking

Results of Molecular Docking As Descriptors to Predict Human Serum Albumin Binding Affinity.

Molecular Interaction Study of Flavonoid Derivative 3d with Human Serum Albumin Using Multispectroscopic and Molecular Modeling Approach

Binding of a potential anti-hepatoma drug cis,cis,trans-[Pt(NH3)2Cl2(O2CCH2CH2COOH)-(OCONHC16H33)] with serum albumin – thermodynamic and conformational investigations

Spectroscopic and Molecular Docking Studies of Binding Interaction of Gefitinib, Lapatinib and Sunitinib with Bovine Serum Albumin (BSA).

Spectroscopic and Molecular Docking Approaches for Investigation of Interaction of Phellopterin with Human Serum Albumin

The Interaction of Dihydromyricetin with Human Serum Albumin by Spectroscopic Methodologies and Molecular Docking

Binding behavior of trelagliptin and human serum albumin: Molecular docking, dynamical simulation, and multi-spectroscopy

Characterization of the binding of an anticancer drug, lapatinib to human serum albumin

In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multi-spectroscopic and molecular docking methods.

Exploring the molecular basis of tucatinib interaction with human serum albumin: A spectroscopic and computational analysis

Multispectroscopic, electrochemical and molecular docking approaches on binding comparison of camptothecin, 10-hydroxycamptothecin to bovine serum albumin

Binding Interaction of Sorafenib with Bovine Serum Albumin: Spectroscopic Methodologies and Molecular Docking.

Domain-specific Interactions Between MLN8237 and Human Serum Albumin Estimated by STD and WaterLOGSY NMR, ITC, Spectroscopic, and Docking Techniques

Analysis on the interaction and binding properties of daphnoretin and human serum albumin in the presence of cisplatin: multi-spectroscopic methods and docking simulation

In Vitro Characterization for Human Serum Albumin Binding Sorafenib, A Multi Kinase Inhibitor: Spectroscopic Study

Isothermal titration calorimetry and stopped flow circular dichroism investigations of the interaction between lomefloxacin and human serum albumin in the presence of amino acids

Effects of Human Serum Albumin on the Fluorescence Intensity and Tumor Imaging Properties of IR‐780 Dye